MaxCyte Inc (NAS:MXCT)

Q4 2024 MaxCyte Inc Earnings Call Transcript

Mar 11, 2025 / 08:30 PM GMT

Release Date Price: $3.47 (+1.46%)

Transcript 10-K8-K

Key Points

Positve

MaxCyte Inc (MXCT) reported a strong year in 2024 with a return to core revenue growth and strategic improvements in operations.
The acquisition of SecureDX is expected to enhance MaxCyte's offerings by providing safety assessments in cell and gene therapy development.
MaxCyte's core business revenue reached $32.5 million, at the high end of their pre-announced range.
The company expanded its SPL portfolio significantly, with 6 new SPL agreements signed in 2024.
MaxCyte ended 2024 with a strong cash position of $190.3 million and no debt, indicating financial stability.

Negative

Total revenue for 2024 declined by 6% compared to 2023, primarily due to multiple approval milestones received in the previous year.
Instrument revenue was impacted by customer caution on capital expenditure, leading to a decrease from $8.3 million in 2023 to $7.1 million in 2024.
Gross margin decreased to 74% in Q4 2024 from 90% in Q4 2023, indicating pressure on profitability.
SPL program-related revenue decreased from $11.5 million in 2023 to $6.1 million in 2024.
The operating environment remains challenging, with no significant improvement in the macroeconomic conditions expected in 2025.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MXCT.OQ - MaxCyte Inc
Q4 2024 MaxCyte Inc Earnings Call
Mar 11, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by and welcome to MaxSite's 4th quarter earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press 11 on your telephone.

If your question has been answered and you'd like to remove yourself from the queue, simply press 11 again. As a reminder, today's program is being recorded, and now I'd like to introduce your host for today's program, Eric Abdel Investor Relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.